PKD1 mediates negative feedback of PI3K/Akt activation in response to G protein-coupled receptors

Yang Ni1, James Sinnett-Smith, Steven H Young

  • 1Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, CURE: Digestive Diseases Research Center and Molecular Biology Institute, University of California at Los Angeles, Los Angeles, California, United States of America ; Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University, Jinan, China.

Plos One
|September 17, 2013
PubMed

Insights

Protein kinase D1 (PKD1) inhibits PI3K/Akt signaling in intestinal cells. Inhibiting PKD1 boosts Akt phosphorylation, indicating PKD1

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Gastroenterology

Background:

  • The PI3K/Akt pathway is crucial for intestinal epithelial cell function.
  • G protein-coupled receptor (GPCR) agonists regulate intestinal epithelial cell signaling.
  • The role of protein kinase D1 (PKD1) in modulating PI3K/Akt signaling in intestinal cells is not fully understood.

Purpose of the Study:

  • To investigate whether PKD1 mediates negative feedback on PI3K/Akt signaling in intestinal epithelial cells.
  • To determine the effect of GPCR agonists on PKD1-mediated regulation of Akt phosphorylation.

Main Methods:

  • Using intestinal epithelial cell lines (IEC-18) and PKD family inhibitors (kb NB 142-70, CRT0066101).
  • Employing siRNA to knock down PKD1 expression.
  • Monitoring Akt phosphorylation at Thr308 and Ser473.
  • Assessing phosphatidylinositol (3,4,5)-trisphosphate (PIP3) accumulation using Akt-PH-GFP.
  • Utilizing a specific inhibitor (A66) for the PI3K p110α subunit.
  • Examining p85α phosphorylation and PTEN association.
  • Comparing Akt phosphorylation in transgenic mice overexpressing PKD1 versus wild-type littermates.

Main Results:

  • PKD1 inhibition potentiated Akt phosphorylation in response to GPCR agonists like angiotensin II (ANG II), vasopressin, and lysophosphatidic acid.
  • PKD1 knockdown also enhanced Akt phosphorylation upon ANG II stimulation.
  • PKD1 inhibition increased PIP3 accumulation at the plasma membrane.
  • ANG II increased p85α phosphorylation and PTEN association, modulated by PKD1.
  • PKD1 overexpression reduced Akt phosphorylation in intestinal epithelial cells in vivo.

Conclusions:

  • PKD1 activation mediates feedback inhibition of PI3K/Akt signaling in intestinal epithelial cells.
  • This regulatory mechanism is relevant both in vitro and in vivo.
  • PKD1 plays a significant role in controlling intestinal epithelial cell growth and survival signaling.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...